Evidence for class-specific factors in immunoglobulin isotype switching by Shanmugam, A. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Women’s Health Research Faculty Publications Women's Faculty Committee 
2000-04-17 
Evidence for class-specific factors in immunoglobulin isotype 
switching 
A. Shanmugam 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/wfc_pp 
 Part of the Life Sciences Commons, Medicine and Health Sciences Commons, and the Women's 
Studies Commons 
Repository Citation 
Shanmugam A, Shi MJ, Yauch L, Stavnezer J, Kenter AL. (2000). Evidence for class-specific factors in 
immunoglobulin isotype switching. Women’s Health Research Faculty Publications. https://doi.org/
10.1084/jem.191.8.1365. Retrieved from https://escholarship.umassmed.edu/wfc_pp/191 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Women’s Health 
Research Faculty Publications by an authorized administrator of eScholarship@UMMS. For more information, please 
contact Lisa.Palmer@umassmed.edu. 
 J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/2000/04/1365/16 $5.00
Volume 191, Number 8, April 17, 2000 1365–1380
http://www.jem.org/cgi/current/full/191/8/1365
 
1365
 
Evidence for Class-specific Factors 
in Immunoglobulin Isotype Switching
 
By Ananth Shanmugam,
 
*
 
 Meng-Jiao Shi,
 
‡
 
 Lauren Yauch,
 
*
 
Janet Stavnezer,
 
‡
 
 and Amy L. Kenter
 
*
 
From the 
 
*
 
Department of Microbiology and Immunology, University of Illinois College of Medicine, 
 
Chicago, Illinois 60612; and the 
 
‡
 
Department of Molecular Genetics and Microbiology and the 
Program in Immunology and Virology, University of Massachusetts Medical School, Worcester, 
Massachusetts 01655
 
Abstract
 
Immunoglobulin class switch recombination (SR) occurs by a B cell–specific, intrachromo-
somal deletional process between switch regions. We have developed a plasmid-based transient
transfection assay for SR to test for the presence of transacting switch activities. The plasmids
are novel in that they lack a eukaryotic origin of DNA replication. The recombination activity
of these switch substrates is restricted to a subset of B cell lines that support isotype switching
on their endogenous loci and to mitogen-activated normal splenic B cells. The factors required
for extrachromosomal plasmid recombination are constitutively expressed in proliferating
splenic B cells and in B cell lines capable of inducibly undergoing immunoglobulin SR on their
chromosomal genes. These studies suggest that mitogens that induce switching on the chromo-
some induce accessibility rather than switch recombinase activity. Finally, we provide evidence
 
for two distinct switching activities which independently mediate
 
 
 
m
 
fi
 
a
 
 
 
and
 
 
 
m
 
fi
 
g
 
3
 
 
 
SR.
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Introduction
 
Ig isotype switching leads to diversification of the humoral
immune response effector functions. Stimulation of mature
B cells leads to expression of new Ig H chain C region
genes, while maintaining the same antigen binding speci-
 
ficity. The murine IgH locus is composed of multiple C
 
H
 
genes,
 
 
 
m
 
,
 
 
 
d
 
,
 
 
 
g
 
1,
 
 
 
g
 
2b,
 
 
 
g
 
2a, 
 
g
 
3,
 
 
 
e
 
,
 
 
 
and
 
 
 
a
 
,
 
 
 
each of which are
coupled with unique switch (S)
 
1
 
 regions, except 
 
d
 
. Isotype
switching focuses on S DNA, and produces new hybrid
DNA combinations. The composite S
 
m
 
-Sx DNA configu-
ration is formed on the chromosome while the intervening
genomic material is looped out and excised as a circle
 
 
 
(1–
4)
 
. 
 
The presence of double-strand breaks (DSBs) in S
DNA
 
 
 
(5),
 
 
 
and the dependency of switch recombination
(SR) on the DNA-dependent protein kinase catalytic sub-
unit (DNA-PK
 
cs
 
 [6]), Ku80
 
 
 
(7), and Ku70
 
 
 
(8), components
of the DNA-PK complex involved in DSB repair, strongly
suggest that SR is resolved through a nonhomologous
DNA end–joining process (for a review, see reference 9).
However, the factors and processes that facilitate SR have
not been defined.
Two views of the regulation of SR have been articu-
lated. In one model, S region–specific recombinases have
been postulated based on the unique character of each S
region
 
 
 
(10, 11).
 
 
 
In the second model, specificity of the SR
process is achieved through production of germline tran-
script, (gts) (12–16)
 
 
 
and a single recombinase. Gts are
RNA transcripts from specific unrearranged C
 
H
 
 genes that
are induced before SR, and initiate upstream of S DNA,
terminate downstream of the C
 
H
 
 gene, and appear not to
be translated. The mechanism whereby gt production reg-
ulates isotype-specific SR is unknown.
Evidence suggests that gt expression is necessary but not
sufficient for SR to occur. Treatment of B cells with acti-
vators and cytokines, or alteration of transcription factor
expression can lead to changes in SR activity without cor-
responding changes in gt expression
 
 
 
(17). The combina-
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, DNA-dependent pro-
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A Plasmid-based Transient Transfection Assay for Switch Recombination
 
tion of dextran-conjugated anti-IgD antibodies (
 
ad
 
dex),
which stimulates B cells to proliferate, and IL-4, which in-
duces 
 
g
 
1 gt expression, does not lead to an increase of
 
m
 
fi
 
g
 
1 switched B cells
 
 
 
(18, 19).
 
 
 
The addition of IL-5 to
these inducers stimulates
 
 
 
m
 
fi
 
g
 
1 SR, suggesting that factors
distinct from gts and cell proliferation are required to sup-
port SR
 
 
 
(19). Furthermore, splenic B cells in which nu-
clear factor (NF)-
 
k
 
B/Rel transcription factors have been
disrupted by targeted recombination have selective defects
in gt expression and isotype switching
 
 
 
(17).
 
 
 
B cells defi-
cient in the COOH-terminal transactivation domain of
c-Rel (
 
D
 
c-rel) express 
 
a
 
 and 
 
e
 
 gts, but switch only
 
 
 
m
 
fi
 
a
 
 
 
and
not
 
 
 
m
 
fi
 
e
 
 (20). Similarly, B cells deficient in p105, which
encodes the p50 of NF-
 
k
 
B, express 
 
g
 
1 and 
 
a
 
 gts, but
switch
 
 
 
only
 
 
 
m
 
fi
 
g
 
1 and not
 
 
 
m
 
fi
 
a
 
 (21). These findings sug-
gest that there are specific factors that function in SR inde-
pendent of gts, and that affect recombination to particular
S regions.
Several plasmid-based recombination assays have been
devised to study SR using both transient and stable trans-
fection
 
 
 
(22–32).
 
 
 
Although many of these plasmid assays
have shown some preference for recombination in B cells
and B cell lines
 
 
 
(26, 29, 31), recombination on these
switch substrates is not restricted to B cells as is physiologi-
cal SR
 
 
 
(22, 24, 29),
 
 
 
or is not completely dependent on S
sequences for recombination (22, 24, 29, 31). While it is
likely that some of the recombination events scored on
these plasmids arise through SR, it is often difficult to dis-
tinguish between specific and nonspecific rearrangements.
Previous analyses did not include a comparison of switch
plasmid recombination in B cell lines capable of endoge-
nous SR and those that do not support SR. In these earlier
studies, plasmid-based SR was found in many mature B
cell lines and led to the suggestion that switch recombinase
activities are broadly expressed in B cells. A new switch
plasmid was recently devised that displayed some specific-
ity for B cell lines that switch, in stable transfection experi-
ments (33). However, the use of stable transfection meth-
ods to study SR is cumbersome.
Here we report that a novel plasmid-based transient
transfection assay for SR tests for the presence of transact-
ing factors. The plasmid substrates lack a eukaryotic origin
of replication
 
 
 
(33). DNA sequence analysis of recombinant
S–S junctions derived from switch plasmids indicates direct
S–S joining. Thus, plasmid-based SR can occur in the ab-
sence of an origin of DNA replication. These switch plas-
mids undergo recombination only in cell lines capable of
switching their endogenous genes and in activated splenic
B cells. The switching cell lines do not require mitogen or
cytokine activation to support SR on plasmid substrates,
suggesting that the switching activities are constitutively
expressed. Furthermore, comparison of the recombination
potential of
 
 
 
m
 
fi
 
a
 
 
 
and
 
 
 
m
 
fi
 
g
 
3 specific switch substrates in-
dicates that recombination activity on the plasmids strictly
correlates with isotype-specific switching at the endoge-
nous loci and suggests that isotype-specific factors may reg-
ulate SR.
 
Materials and Methods
 
Construction of Plasmids.
 
p273, p200, and p218 were de-
scribed previously (33). To obtain pG3.
 
D
 
I
 
aD
 
EP, the complete
2.0-kb Balb/c genomic S
 
g
 
3 region was amplified (34). The S
 
g
 
3-
PCR product was cloned into the XbaI site of Bluescript KS
 
2
 
.
The cloned S
 
g
 
3 was then excised as a BamH1–NotI fragment
and cloned into gel-purified p218, from which the S
 
a
 
 fragment
had been excised by a BamHI–NotI digestion. To obtain
pG3.
 
D
 
I
 
a
 
 from pG3.
 
D
 
I
 
aD
 
EP, EP was cloned in the forward ori-
entation into the unique ClaI site located upstream of S
 
m
 
 in
pG3.
 
D
 
I
 
aD
 
EP. EP is composed of the 0.7-kb IgH core intronic
enhancer and a 0.3-kb fragment containing the VH186.2 pro-
moter (35). To obtain pG3.
 
D
 
EP from pG3.
 
D
 
I
 
aD
 
EP, the germ-
line 
 
a
 
 promoter (I
 
a
 
) was PCR-amplified from I.29m DNA using
forward (2489/2469; 59 GGC CGC GGA CCC TGT GAC
CTC AAA GCT CT 39 and reverse (133/113; 59 GGG CGG
CCG CTC TGT GTG TGA TTG CCT GTG 39) primers (36)
and cloned into the SmaI site of pUC 18. The Ia segment in-
cludes nucleotides 2488 to 130, relative to the first RNA initia-
tion site (sequence data are available from EMBL/GenBank/
DDBJ under accession no. L04145 [36]). Ia was excised as an
XbaI–NotI fragment (the primer carries a NotI site), and was
cloned in the physiological orientation into the BamHI site of
pG3.DIaDEP. To obtain pG3.1, EP fragment was cloned in the
forward orientation into the ClaI site of pG3.DEP. The plasmid
p208 is identical to p218, except for the addition of the Ia frag-
ment. To obtain p208, the Ia fragment was cloned in the physio-
logical orientation into the BamHI site of p218. To obtain
pG3.1.01s, two partially complementary oligonucleotides were
synthesized such that the sense oligo was representative of 2439–
2508 and the antisense was representative of 2568–2488 of the
Balb/c genomic Sg3 sequence (MUSIGHANA). The oligos
were annealed, filled-in with Klenow DNA polymerase (Pro-
mega) and cloned. A plasmid containing thymidine kinase gene
(TK), Ia, and the Sg3 cloned oligos was constructed. This insert,
TK.Ia.Sg3 oligo, was isolated as a cassette and cloned into pG3.1,
which had been digested with EcoRI and NotI.
For pGL3-SV40, the SV40 enhancer/promoter was excised
from pRL-SV40 vector (Promega) and cloned upstream of the
firefly luciferase gene of the pGL3 basic vector (Promega). For
pIa-Luc, the Ia fragment, was cloned into pGEM-T Easy ac-
cording to the manufacturer’s instructions (Promega). The cloned
Ia segment was excised from pGEM-T Easy by EcoRI digestion,
isolated from an agarose gel, and the ends were filled in using
Klenow DNA polymerase. The resulting Ia fragment was ligated
into pXP2, a luciferase reporter vector that lacks a promoter or
enhancer (37, 38), which had been digested with SalI and treated
with Klenow DNA polymerase. Nucleotide sequencing was per-
formed to verify the correct promoter sequence. For pIaE-Luc,
the Ig m intron enhancer (E), was obtained by digestion of p273
with HindIII to excise the EP fragment, which was isolated from
an agarose gel, and ligated into the HindIII site in pUC19. pUC-
EP was then digested with HindIII and BamHI to excise the E
fragment alone. The ends were filled in using Klenow DNA
polymerase, and the E segment was inserted at the filled-in Hind-
III site of pXP2 upstream of the Ia promoter segment.
Cell Culture, Transfection, Luciferase Assays, DNA Isolation, and
Hirt Extracts. Splenic B cells were prepared and grown as de-
scribed previously (39). In brief, spleens were removed from 8–12-
wk-old Balb/c nu/nu mice and a single cell suspension was pre-
pared. The cells were washed twice in HBSS or RPMI 1640
supplemented with 2% FCS (Hyclone). Cells were resuspended
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in 1 ml of HBSS and underlaid with 3 ml of Ficoll-Paque (Amer-
sham Pharmacia Biotech) and centrifuged at 1,200 g for 20 min at
room temperature. Cells were recovered from the Ficoll, washed
extensively, and then seeded at 5 3 105 cells/ml and cultured in
RPMI 1640, 20% FCS, 4 mM glutamine, penicillin-streptomy-
cin, 5 3 1025 M 2-ME and cultured in 6% CO2. Cells were acti-
vated for a minimum of 40 h in either 50 mg/ml LPS (Salmonella
typhimurium, phenol extract, Westphal; Sigma Chemical Co.), or
in 3 ng/ml anti-IgD–coupled addex beads (a gift from C. Snap-
per, Uniformed Service, University of Health Sciences, Bethesda,
MD) before electroporation. I.29m and CH12.LX were grown as
described (40, 41). The conditions for 1B4.B6 cell growth were
identical to those for CH12.LX, except that serum was specifi-
cally screened for its ability to support SR in this cell line (our
unpublished results). The cell lines A20, M12, BW5147, EL4,
and P388D1 were grown as described previously (39). Bal17 was
grown as described (42). Cells were electroporated in the pres-
ence of 10 mg of plasmid DNA at 0.28–0.33 kV at 960 mF in a
Gene Pulser (Bio-Rad), cultured for 2 d, and total genomic DNA
was isolated from 5 3 106 cells using the Genomic DNA isolation
kit (Gentra Systems), or from nuclei prepared using the Blood
and Cell Culture DNA Preparation kit (Qiagen). Hirt extracts
were prepared by isolating nuclei and obtaining low molecular
weight DNA using the Qiaprep Spin Mini Prep Kit (Qiagen).
Cells cotransfected with pGL3-SV40 were cultured for 48 h, and
an aliquot of cells (0.5 3 106) was analyzed for luciferase activity
(Promega).
Two luciferase reporter plasmids, pIa-Luc and pIaE-Luc,
were used to assay transcriptional activity in cell lines. Transfec-
tions were performed as described previously (36). Two different
internal control plasmids were used as controls for transfection ef-
ficiency: pSV2-CAT (43), containing the chloramphenicol acetyl
transferase (CAT) gene, and pPGKb-gal, containing the b-galac-
tosidase (b-gal) gene driven by PGK promoter (44), obtained
from P. Dobner (University of Massachusetts Medical School).
Cells were then cultured at 1–2 3 106/ml for 24 h, and assayed
for luciferase activity and either CAT (45) or b-gal activity (46).
PCR of S–S Recombinant Molecules and Southern Analysis. To-
tal DNA isolated from transfected cell lines was normalized for
plasmid concentration based on luciferase activity values. Sm–Sg3
recombinant molecules were amplified using the m-1A primer, 59
CTC TAC TGC CTA CAC TGG ACT GTT CTG 39, and g3-
2.2 primer, 59 CCT GGG ACC CTG TGA TCT GAT AGC
C39, located 39 of Sg3, as described (34) with modifications. Sm–
Sa recombinant molecules were amplified using the m-1A primer
and the a-R11 primer, 59 CTC TAT CTA GGT CTG CCC
GGT CTA GGT AAG 39. The Expand Long Template PCR
system (Boehringer Mannheim) was used according to manufac-
turer’s instructions with modifications. PCR was a total of 36 cy-
cles using a thermocycler (model 480; Perkin Elmer). Primers
were annealed at 648C for 40 s and elongation time was 4 min at
688C for 10 cycles. A further 26 cycles were carried out with an
elongation time of 4 min, with an additional 20 s added for each
cycle. DNA recovered from transfected cells was digested with
EcoRI before PCR to linearize intact plasmid. A segment of the
neomycin gene was amplified using P1 primer (forward), 59 GTA
ATA CGA CTC ACT ATA GGG C 39, and P5 primer (re-
verse), 59 ATG GCC GCT TTT CTG GAT TC 39. PCR was
performed using Taq polymerase (Boehringer Mannheim) and an
initial denaturation at 948C for 2 min was followed by 26 cycles
with each cycle consisting of 938C for 30 s, 558C for 40 s, 728C
for 2 min 30 s, and a final elongation step at 728C for 10 min.
Amplification products were visualized by electrophoresis on 1%
agarose gels containing ethidium bromide. Southern analyses
were performed by standard methods. The filters were sequen-
tially hybridized with radioactive Sm, TK, Sg3, or Sa probes pre-
pared using the random labeling kit (New England Biolabs) and
quantitated by PhosphorImager® analysis (Molecular Dynamics).
Digestion-circularization PCR. Digestion-circularization (DC)-
PCR analysis for the switch plasmids was performed as described
previously (25) with modifications. 1 mg of genomic DNA, or 5
of 50 ml of Hirt extracts from nuclei, was digested overnight with
20 U of SacI (Promega) in the presence of 2 mM spermidine in a
total volume of 50 ml. After heat inactivation, 4 ml of digested
DNA was ligated overnight using 6 U of T4 DNA ligase
(Promega) in a total volume of 40 ml. After heat inactivation, 1 ml
of the ligated DNA was used for PCR amplification. The 510-bp
fragment was amplified using primers P1, 59 GTA ATA CGA
CTC ACT ATA GGG C 39, and P4, 59 CCC GAC TGG AAA
GCG GGC AGT GAG CGC AAC 39. PCR amplification was
in the presence of 3 mCi of [a-32P]dCTP and was carried out for
26 cycles with each cycle consisting of 938C for 30 s, 608C for 40 s,
and 728C for 1 min 30 s, followed by a final step at 728C for 10
min. Amplification of the 180-bp fragment was as described
above, except that PCR consisted of 36 cycles and was per-
formed using the P2/P3g or P2/P3a primer sets: P2, 59 TTT
CAG ATC AGC TCA CCG CAA CAC AGC GTA GCA T 39;
P3g, 59 GGG TTG GAT GGA AAT GTG AAT AAC CTG
CCT GA 39; and P3a, 59 CCT AGA CCG GGC AGA CCT
AGA TAG AGT TGC 39, which is the reverse sequence of the
R11 primer. To control for efficiency of digestion and ligation,
DC-PCR amplification of the 180- and 510-bp fragments was
carried out from the same ligation reaction. To establish the lin-
ear range of detection, serial dilutions of plasmid DNA were
mixed with 1 mg of genomic DNA and analyzed by DC-PCR
for the 510-bp fragment. PCR products were purified by a phe-
nol and chloroform extraction and then 1/5 (10 ml) of the sample
was analyzed on 4% nondenaturing TBE polyacrylamide gels and
quantitated by PhosphorImager® analysis. Further experimental
details are available upon request.
Results
Structure of the SR Plasmid Substrates. To identify factors
that participate in the SR reaction, we devised a plasmid-
based transient transfection assay (Fig. 1 A). The switch
substrate, p273, is specific for mfi a SR events (33; Fig. 1
A). Intact, p273 contains a neomycin-resistance gene (neo),
the Ig intronic enhancer (Em), an IgH variable region pro-
moter (PH), a TK, the TGF-b inducible promoter for a gts
(Ia), and the Sm and Sa regions, with an overall configura-
tion of 59-neo-Em-PH-Sm-TK-Ia-Sa-39. Transcription
through the Sm and Sa regions is initiated by the PH and Ia
promoters, respectively. The TK and Ia segment would be
deleted as a consequence of S–S recombination. This dele-
tion will confer gancyclovir resistance to cells. However, as
explained below, gancyclovir selection is found to be un-
necessary. To assay mfi g3 recombination, pG3.1 was con-
structed from p273 by replacing Sa with Sg3 DNA (Fig. 1
A). These switch substrates are distinguished from those
devised by others (24, 29) by the absence of a polyoma ori-
gin of replication. The rationale for this omission is that this
origin may cause a significant frequency of background re-
arrangements between S sequence and vector.
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Transcription across S regions and expression of gts is
necessary for isotype switching in vivo (12, 15, 47, 48). B
cell–specific promoters, PH and Ia, and the enhancer, Em,
were incorporated into the switch substrates to accommo-
date the possible dependence of SR on these transcriptional
control elements (Fig. 1 A). In this context, it was impor-
tant to establish that the promoters and enhancer used in
the switch plasmids were active in all cell lines used in this
study. Transcriptional activity of the Ia promoter alone, or
in combination with Em, was analyzed using luciferase re-
porter plasmids, pIa-luc and pIaE-luc, respectively, and
found to be present in the B cell lines I.29m, CH12.LX,
1B4.B6, Bal17, M12, and A20, and in the T cell line, EL4
(Fig. 1 B). These transcriptional elements were minimally
active in the T cell line, BW5147, but not in the macro-
phage/monocyte line, P388D1. As these B cell lines produce
Ig, we presume that the VH promoter and Em are tran-
scriptionally active. Cell lines that are able to support tran-
scription at levels comparable to that found in I.29m are
candidates for the analysis of plasmid-specific SR.
Detection of S–S Recombinant Plasmids in Transient Trans-
fections by Direct PCR. SR occurs anywhere within the
donor and acceptor S regions, and produces a population of
S–S recombinant fragments heterogenous in size and struc-
ture. On the switch plasmids, successful SR is predicted to
result in the deletion of the TK and Ia segment, and for-
mation of a heterogeneous population of Sm–Sa and Sm–
Sg3 hybrid molecules (Fig. 1 A). As described previously,
PCR assays for S–S composite molecules at endogenous
loci (34) and on p273 (33) were modified and adapted to
pG3.1 (Fig. 1 A). When Sm–Sa hybrid molecules are
formed, the distance between primers upstream of Sm (m-
1A) and downstream of Sa (a-R11) is reduced. Compari-
son of the switching potential of p273 and pG3.1 in cell
lines capable of SR relative to that in cell lines devoid of
SR activity may allow definition of parameters that govern
this process. The cell lines, I.29m (40), CH12.LX (41), and
1B4.B6 (Ma, L., H. Wortis, and A.L. Kenter, unpublished
data) are capable of supporting endogenous mfi a SR, and
1B4.B6 is also capable of endogenous mfi g3 SR. No other
mouse cell line is known to be inducible for SR.
The switch substrates were transiently transfected into
various cell lines and analyzed for formation of plasmid-
specific S–S hybrid DNA by PCR amplification followed
by Southern analysis. Cotransfection of a luciferase reporter
plasmid, pGL3-SV40, and measurement of luciferase activ-
ity was used to control for transfection efficiency. To fur-
ther confirm that the concentration of plasmid was equiva-
lent in the normalized samples, a standard curve was set up
for neomycin amplification. PCR amplification of the neo-
mycin gene, which is unique to the switch plasmids, veri-
fied the presence of p273 and pG3.1 in all cell lines ana-
lyzed (Fig. 2, D and H). A standard curve for amplification
of the neomycin gene indicated that the neomycin PCR
products obtained were in the linear range of detection
(data not shown). Thus, PCR amplification of the neomy-
cin gene functioned to independently verify that the trans-
fected samples were successfully normalized. A unique
EcoRI site is located in the TK on the switch plasmid (Fig.
1 A). DNA recovered from transfected cells was digested
with EcoRI before PCR amplification. This treatment de-
stroys the linear integrity of intact or partially rearranged
substrate, and renders these plasmids unavailable for ampli-
fication. Genomic DNA from JI-19 and T22, stable trans-
fectants containing intact p273 and pG3.1, respectively,
were used as positive controls for the PCR reaction and
Figure 1. (A) Schematic diagram of extrachromosomal SR substrates, p273 and pG3.1, and PCR assay for SR. Transcription of the substrate Sm and
Sa regions is mediated respectively by the VH region gene promoter (P) and Ia, a TGF-b1 inducible promoter associated with the a gts (reference 36),
and is induced by the IgH intronic m enhancer (E of EP). Probes (black horizontal bars) used in the Southern hybridization of PCR products are shown.
The position and orientation of S region–specific forward (m-1A) and reverse (g3-2.2 and a-R11) primers are shown by the filled triangles. Plasmid-spe-
cific forward (P1) and reverse (P4) primers, and neomycin-specific reverse (P5) primer (open triangles) are shown. When recombinant S–S regions are
formed on p273 or pG3.1, the distance between the PCR primers, m-1A and a-R11 or g3-2.2 located 59 of Sm and 39 of Sa or Sg3, respectively, is
shortened from 5.7 to 3.3 kb or less. The position of the unique EcoRI (E) site is shown. (B) Analysis of pIa and pIaE luciferase reporter plasmids in var-
ious cell lines. Luciferase reporter plasmids containing Ia (2490/146) in the presence and absence of Em were constructed and are referred to as pIaE
and pIa, respectively. Luciferase activities were assessed 24 h after transfection. Two independent experiments were performed for all cell lines and the
mean luciferase activities and their ranges are reported.
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their amplification products are included as hybridization
controls (Fig. 2, A–C, lane 1, and E–G, lane 9). These
DNAs were not digested with EcoRI before PCR amplifi-
cation.
When DNA from p273 transfectants was analyzed, a
complex mixture of PCR products that hybridize with Sm
and Sa, but not TK, were derived from DNA of 1B4.B6,
subclone 1B4.B6.10, I.29m, and CH12.LX (Fig. 2, A–C).
Few PCR products were obtained from the other cell
lines. When DNA from pG3.1 transfectants was analyzed, a
heterogeneous population of amplified fragments that hy-
bridize with Sm and Sg3, but not TK, were derived from
DNA from 1B4.B6.10, but not from any other cell line
(Fig. 2, E–G). Quantitation of hybridized Sm probe by
PhosphorImager® analysis from two to three experiments,
which included five to nine individual transfected samples,
was averaged for each cell line and the SD was calculated
(Fig. 2 I). This analysis indicates that the amounts of p273-
Figure 2. Switch plasmid–derived S–S
recombinant molecules are detected in a re-
stricted set of B cell lines. (A–H) Cell lines
were cotransfected with a switch plasmid
(10 mg) and pGL3-SV40 (10 mg) and ana-
lyzed after 48 h of culture. One aliquot was
taken for luciferase analysis while DNA was
prepared from a second aliquot. The
amount of DNA taken for PCR was nor-
malized based on luciferase values to control
for transfection efficiency. Before PCR,
DNA was digested with EcoRI to eliminate
intact or partially rearranged plasmid. A
unique EcoRI site is located in the TK (see
Fig. 1 A). (A–C) Cell lines transfected with
p273 were analyzed by PCR amplification
with primer sets m-1A/a-R11 (lanes 1–9)
or m-1A/P4 (lanes 10–12) for the formation
of Sm–Sa composite molecules. The primer
set m-1A/a-R11 nonspecifically amplified
endogenous loci in CH12.LX cells and was
thus replaced with the m-1A/P4 primer set.
A representative example is shown of PCR
products analyzed by Southern hybridiza-
tion using the Sm (A), Sa (B), or TK (C)
probes. JI-19 (lanes 1 and 12) is a stably
transfected I.29m clone carrying an intact
copy of p273 and was not digested with
EcoRI. (E–G) The formation of Sm–Sg3
composite molecules was analyzed by PCR
amplification with primer set m-1A/g3-2.2
(lanes 1–9), followed by Southern hybrid-
ization using the Sm (E), Sg3 (F), or TK (G)
probes. T22 is a stably transfected I.29m
clone carrying an intact copy of pG3.1 and
was not digested with EcoRI. Sizes of se-
lected DNA fragments are shown. Presence
of plasmid DNA p273 (D) and pG3.1 (H)
after transfection was verified by amplifica-
tion of a portion of the neomycin (neo)
gene using the P1/P5 primers. (I) Quantita-
tion of S–S recombinant molecules by
PhosphorImager® analysis of Southern hy-
bridizations. The Southern hybridizations
for each cell line are derived from multiple
independent transfected samples, from two
to three experiments. The number of trans-
fected samples tested for each cell line is in-
dicated. The average hybridization signal,
relative to M12, is shown by the histograms
with SD indicated. (J) PCR amplification
products are plasmid specific. The 1B4.B6,
CH12.LX, and I.29m cell lines were (mock)
transfected in the absence of plasmid, and DNA was isolated from nuclei and tested for the presence of S–S recombinant products using the indicated
primer sets. Two experiments were performed with identical results. (K) Plasmid recovery from transfected cell lines was verified by Southern analysis.
Equal amounts of genomic DNA (4 mg/sample) from the indicated cell lines (lanes 1–9) were digested with SacI and analyzed by Southern hybridization.
As a control for probe specificity, DNA from mock-transfected 1.B4.B6.10 cells was included in lane 10. Plasmid pG3.1 and p273 DNA was digested
with SacI and is shown as a positive control for hybridization, as indicated (lane 11). The probe used was a 1,267-bp BglI restriction fragment from the
Bluescript SK plasmid, containing the ampicillin-resistance gene.
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derived recombinant molecules are .20–40-fold in
1B4.B6, 1B4.B6.10, I.29m, and CH12.LX than in M12
and the other non-switching cell lines tested. The amount
of pG3.1-derived S–S recombinant molecules is .125-fold
in 1B4.B6.10 than in M12 and other cell lines analyzed
(Fig. 2 I). As primers used for amplification of plasmid-
derived S–S recombinant fragments are also capable of detect-
ing fragments from the endogenous loci, DNA samples
from mock-transfected cells were also tested in these same
experiments. No Sm–Sa recombinant fragments that hy-
bridized with Sm were detected in DNA amplified from
1B4.B6, I.29m, and CH12.LX cells, and no Sm–Sg3 re-
combinant fragments were detected in DNA amplified
from 1B4.B6.10 cells (Fig. 2 J). The cell lines 1B4.B6,
1B4.B6.10, I.29m, and CH12.LX require treatment with
mitogen and/or cytokines to induce SR at endogenous
loci. Thus, the absence of S–S recombinant fragments in
DNA from these mock-transfected cells is consistent with
their requirements for SR induction.
Southern analysis was used to independently verify the
presence and integrity of the switch plasmids in representa-
tive samples from each of the transfected cell lines. Ge-
nomic DNA was isolated from cell lines transfected with
pG3.1 or p273 and the luciferase reporter plasmid, digested
with SacI, and analyzed by Southern hybridization using a
probe specific for the plasmid backbone (Fig. 2 K). A DNA
sample from mock-transfected 1.B4B6.10 cells was ana-
lyzed and showed no hybridization with the plasmid-spe-
cific probe, whereas pG3.1 and p273 DNAs hybridized
well, confirming the specificity of the probe (Fig. 2 K, lanes
10 and 11). A 3.2-kb band was evident in all of the DNA
samples, indicating the presence of transfected switch sub-
strate. The varying intensities of plasmid-specific hybridiza-
tion represent the varying transfection efficiencies of the
cell lines as equal amounts of genomic DNA were taken for
analysis. These results indicate that the absence of S–S re-
combinant fragments detected by the direct PCR assay
shown in Fig. 2 cannot be attributed to a failure of plasmid
recovery from transfected cell lines. Together, these find-
ings suggest that S–S recombination on the plasmid occurs
selectively in B cells capable of switching their endogenous
S genes (Table I).
DC-PCR Confirms the Presence of Class-specific Factors for SR.
SR may initiate through formation of DSBs in S DNA
(5). S regions contain short regions of homologous se-
quence (49). Damaged DNA has been shown to promote
formation of gene hybrids during PCR amplification (50,
51). Thus, it is possible that the S–S recombinant fragments
produced by direct PCR amplification of the switch plas-
mids may arise through cleavage of S DNA followed by
PCR-mediated S–S hybrid formation. A semiquantitative
DC-PCR assay (25, 52) was used to determine whether
the apparently composite S–S molecules are physically con-
tiguous and to provide a more quantitative evaluation of
the relative levels of recombination on the plasmids. On
the switch substrate, recombination between two S regions
will cause the deletion of intervening TK and Ia gene seg-
ments and loss of an internal SacI site but conservation of
SacI sites situated in the 59 region of Sm and 39 of Sa and
Sg3 (Fig. 3 A). The recombined S–S hybrid will be located
Table I. Summary of SR Activity at Endogenous Loci and on Switch Substrates in Various Cell Types
Endogenous SR Plasmid* SR
Tissue Literature designation Cell line or type m fi g3 m fi a m fi g3 m fi a
B lymphoid lineage
Mature B cell B cell LPS- and addex-stimulated
splenic B cells, Balb/c nu/nu
1 1 1 1
1B4.B6 J2 virus–transformed
B cell line
1 1 1 1
1.29m Lymphoma 2‡ 1 2 1
CH12.LX Lymphoma 2‡ 1 2 1
M12 Lymphoma 2 2 2 2
A20 Lymphoma 2 2 2 2
Bal17 Lymphoma 2 2 2 2
T lymphoid lineage
BW5147 Lymphoma 2 2 2 2
EL4 Lymphoma 2 2 2 2
Monocytic lineage
P388D1 Macrophage/monocyte 2 2 2 2
*Plasmid-based SR activity assessed by direct S–S PCR and DC-PCR.
‡Rare m fi g3 events have been detected for 1.29m (reference 61) and CH12.LX (reference 80).
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on a new SacI fragment, whereas the unrecombined S re-
gions would be located on two different SacI fragments. Af-
ter digestion with SacI, DNA is ligated under dilute condi-
tions that favor intramolecular ligation, resulting in the
circularization of individual restriction fragments. The region
spanning the circle “joint” is amplified using reverse primers
specific for sites at the 59 end of Sm and the 39 end of Sa or
Sg3. PCR amplification of the S–S composite fragment after
SacI digestion and ligation yields a 180-bp fragment (Fig. 3
A). The size of this DC-PCR product is plasmid specific and
could not be derived from the endogenous locus based on
the position of the genomic SacI sites (53, 54).
To control for transfection, plasmid recovery, and liga-
tion efficiency, a DC-PCR assay for the plasmid backbone
was devised. The plasmid backbone is contained in a single
SacI restriction fragment that will circularize when ligated
under dilute conditions. The DC-PCR of the plasmid
backbone circle joint yields a 510-bp amplification product
(Fig. 3 A). The linear range of detection was established us-
ing twofold serial dilutions of p273 (data not shown), and
pG3.1, into 1 mg of genomic DNA followed by DC-PCR
in the presence of radiolabeled deoxynucleotides. Addition
of increasing amounts of template ranging from 1.25 to 10
ng/ml resulted in a linear increase of vector-specific DC-
PCR product, as shown for pG3.1 (Fig. 3 B). Two stan-
dard samples, 1.25 and 2.5 ng, were taken from this titra-
tion and included in all subsequent studies to assure that the
amplification product deriving from the plasmid backbone
was always in the linear range of detection.
To confirm that the DC-PCR assay was being carried
out under intramolecular ligation conditions, various con-
centrations of pG3.1 plasmid were digested with SacI or
SacI plus BglI. There are two BglI sites located in the plas-
mid backbone (Fig. 3 A). Digestion of the plasmid back-
bone with SacI and BglI will preclude the circularization of
this DNA under dilute ligation conditions. We found that
at 1.25 and 2.5 ng/ml of input plasmid DNA, the 510-bp
DC-PCR product was present after digestion with SacI,
but not with SacI and BglI, verifying the intramolecular
character of this ligation reaction (data not shown). To fur-
ther verify that the DC-PCR assay was being carried out
under intramolecular ligation conditions, the same experi-
ment was performed with pG3.1 DNA recovered from
transfected 1B4.B6.10. The 510-bp DC-PCR product was
detected using plasmid digested with SacI, but not with
SacI and BglI, confirming the intramolecular character of
this ligation reaction (Fig. 3 C).
To confirm that the conditions chosen for intramolecu-
lar ligation were also valid for the 180 bp DC-PCR prod-
uct, we tested for the presence of the 180-bp DC-PCR
product from pG3-1 using a range of concentrations of
plasmid that had been digested with SacI. At high concen-
trations of input plasmid, intermolecular ligation occurred
and produced the 180-bp DC-PCR product (Fig. 3 B,
lanes 1 and 2). As expected, under dilute plasmid concen-
trations (0.62–5 ng) no 180-bp product was detected, dem-
onstrating that fragment ligation was intramolecular (Fig. 3
B, lanes 3–6).
Figure 3. Semiquantitative DC-PCR analysis of switch substrate–
derived S–S composite molecules. (A) Schematic diagram of the DC-PCR
assay is shown for pG3.1 and is essentially identical for p273. SacI diges-
tion of pG3.1 releases Sm and Sg3 as separate restriction fragments,
whereas in the recombined substrate the S–S recombinant molecule is re-
leased as a single restriction fragment. Ligation is performed such that in-
tramolecular restriction fragment circularization is favored. PCR using
the P1/P4 primer set amplifies a 510-bp fragment derived from the vector
backbone. PCR with primer set P2/P3g leads to the amplification of a
180-bp fragment derived from the S–S recombinant fragment. (B) DC-
PCR products are in the linear range of detection. Twofold serial dilu-
tions of the pG3.1 were titrated into 1 mg of genomic DNA and analyzed
by DC-PCR (top). The PCR amplification signals for the 510-bp frag-
ment were plotted against the concentration of input plasmid DNA (bot-
tom), and served to determine a standard curve and the range of linear
detection. Two samples (1.25 and 2.5 ng), which are in the linear range
of detection, were included in every subsequent analysis. (C) Verification
of the intramolecular ligation for the vector DC-PCR assay. The pG3.1
plasmid was transfected into 1B4.B6.10 cells, nuclei were isolated, DNA
was recovered and digested with either SacI or SacI plus BglI, and the
DC-PCR assay was performed.
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DC-PCR analysis of switch substrates transiently trans-
fected into a panel of cell lines was conducted. To compare
plasmid-based SR between cell lines, a relative recombina-
tion level (RRL) is calculated for each cell line from the ra-
tio of radioactivity associated with the 180-bp fragment to
that of the 510-bp fragment and by arbitrarily setting the
RRL for M12 at 1.0 (Fig. 4 A). Recombination of pG3.1
is undetectable in I.29m, CH12.LX, M12, and EL4,
whereas switching activity is found in 1B4.B6 and
1B4.B6.10 with RRLs of 100–200-fold above background
(Fig. 4 A). Switching activity for p273 is undetectable in
M12 and EL4, whereas activity is found in 1B4.B6,
1B4.B6.10, I.29m, and CH12.LX with RRLs 80–200-fold
above background (Fig. 4 A). As a control for plasmid
specificity of the 180-bp DC-PCR product, cell lines that
supported SR on pG3.1 and p273 were mock transfected
in the absence of plasmid, and then DNA was isolated and
analyzed by DC-PCR using the indicated primer sets (Fig.
4 B). No 180-bp product was detected in the mock-trans-
fected cell lines, indicating the plasmid specificity of this
PCR product. A p273 plasmid containing a recombined S–S
region was included as a positive control for ligation and
PCR amplification. This recombined plasmid gave rise to
the 180-bp product as expected (Fig. 4 B). The DC-PCR
analysis verifies that S–S fragments amplified by direct PCR
are organized as covalently joined contiguous units before
PCR. This analysis also demonstrates that mfi g3 switching
activity is present only in 1B4.B6 cells, whereas p273 mfi a
recombination occurs in I.29m, CH12.LX, and 1B4.B6
cells.
To determine if the plasmids could undergo SR in nor-
mal B cells, p273 and pG3.1 were transfected into LPS-
activated splenic B cells (55) from nu/nu mice, which lacked
T cells, and were analyzed by DC-PCR. LPS is a well-
characterized B cell mitogen that causes B cell proliferation,
Ig secretion, and SR (55). The DC-PCR analysis indicates
the presence of S–S recombinant fragments in p273 and
pG3.1, confirming that the plasmids are recombinogenic in
cells that undergo physiological SR (Fig. 4 A).
Incomplete digestion of the switch plasmid DNAs with
restriction enzymes could lead to false positive results in the
DC-PCR assay (Fig. 3 A). Several additional controls were
performed to test for incomplete digestion. DNA isolated
from CH12.LX, I.29m, M12, 1.B4B6.10, and from LPS-
activated splenic B cells transfected with pG3.1 or p273
was digested with both EcoRI and SacI, instead of only
SacI, before analysis by DC-PCR (Fig. 5). The addition of
EcoRI has no effect on the presence of the 510-bp frag-
ment (Fig. 5 A), as there are no EcoRI sites in the vector
backbone (Fig. 3 A). However, digestion of the DNAs
with EcoRI, SacI, and BglI abolished the 510-bp fragment
in all samples (Fig. 5 B) because there are two BglI sites lo-
cated in the vector backbone (Fig. 3 A). The absence of the
510-bp fragment under these conditions indicates that the
switch plasmid DNA can be digested to completion and
that ligation was exclusively intramolecular. Intact switch
substrates contain an EcoRI site in the TK, whereas after
SR the recombinant plasmids contain no EcoRI sites (Fig.
1 A). Digestion of the DNA samples with EcoRI has no ef-
fect on the presence of the 180-bp fragment from either
pG3.1 or p273 (Fig. 5 C). The pG3.1 plasmid contains a
BglI site at the 39 end of the Sg3 region, whereas a compa-
rable site is absent from p273. Digestion of the DNA sam-
ples with EcoRI, SacI, and BglI abolished the 180-bp frag-
ment in the pG3.1 samples but not in the p273 samples,
indicating that these switch plasmid samples can be cut to
completion by restriction enzymes. The specificity of the
DC-PCR reaction was further confirmed by the absence of
the 180 bp fragment in DNAs derived from M12 cells
transfected with p273 (Fig. 5 C, lanes 10 and 11). Taken
Figure 4. The differential activity of p273
and pG3.1 in B cell lines that support en-
dogenous switching as analyzed by DC-
PCR. (A) DC-PCR analysis of DNA from
nuclei derived from cells transfected with ei-
ther pG3.1 or p273 is shown in the upper
panels. PCR using the P1/P4 primer set
amplifies a 510-bp fragment derived from
the vector backbone. PCR with primer set
P2/P3g or P2/P3a amplifies the 180-bp
fragment representing the S–S recombinant
fragments from pG3.1 and p273, respec-
tively. Normal splenic B cells from Balb/c
nu/nu mice were activated with LPS, trans-
fected with the switch plasmids, and ana-
lyzed by DC-PCR as indicated. The aver-
age RRL of four transfections in two
independent experiments for each cell line
for p273 and pG3.1 is plotted (bottom) and
SDs are shown. (B) As a control for plasmid
specificity of the 180-bp S–S DC-PCR product, cell lines (1B4.B6.10, I.29m, and CH12.LX) exhibiting high levels of SR on pG3.1 and p273 were
(mock) transfected in the absence of plasmid, and nuclei were prepared and analyzed by DC-PCR for presence of the 180-bp fragment. A recombinant
p273 plasmid mixed in with genomic DNA was included as a positive control. (C) DC-PCR analysis of Hirt extracts indicates that SR occurs in the ab-
sence of DNA replication. Switch plasmids, pG3.1 or p273, were transiently transfected into various cell lines and after 48 h of cell culture, nuclei were
harvested and Hirt extracts were made. DC-PCR analysis for vector and S–S recombinant fragments was carried out on the Hirt supernatants as indicated.
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together, the use of additional restriction enzyme combina-
tions confirms that the 180-bp fragment, representing the
presence of S–S recombinant plasmid substrates, arises from
bona fide recombination events.
SR on the Plasmid Substrate Is Not Dependent on an Origin
of DNA Replication. The requirement for cycling cells in
the SR reaction was previously noted (56–59). The switch
plasmid cannot autonomously replicate at high levels, as it
does not contain an origin of replication (Fig. 1 A). If high-
level DNA replication is an intrinsic requirement for SR,
then extrachromosomal switch substrates will not support
plasmid-based SR and must integrate into genomic DNA
in order to replicate and recombine. Isolation of low mo-
lecular weight DNA from transfected cells by Hirt extrac-
tion allows examination of the recombination state of
nonintegrated plasmid DNA. DC-PCR analysis of extra-
chromosomal switch plasmids recovered from Hirt extracts
provides evidence for SR on p273 transfected into I.29m
and 1B4.B6 cells, and for pG3.1 in 1B4.B6.10 cells (Fig. 4
C). Again, we find that p273 does not recombine in EL4,
and that pG3.1 does not recombine in I.29m or EL4. These
results indicate that SR on the switch substrate can occur in
the absence of a DNA origin of replication.
Structural Analysis of p273 Recovered from Cell Lines by Bac-
terial Transformation. Recovery of recombinant switch
substrates provides an opportunity to examine the full
range of structures that arise in switching and nonswitching
cell lines. We found that switch plasmid could be most eas-
ily recovered from preparations of genomic DNA by bac-
Figure 5. The authenticity of the DC-PCR products was verified by
restriction enzyme analysis. DC-PCR analysis of DNA from nuclei de-
rived from LPS-activated splenic B cells transfected with either pG3.1
(lanes 1–4) or p273 (lanes 5–7) and from cell lines transfected with p273 is
shown (lanes 8–12). The samples shown in lanes 1–12 were derived from
independent transfections. Genomic DNA from transfected cells was di-
gested with combinations of enzymes including EcoRI plus SacI (A and
C, E/S), or EcoRI plus SacI plus BglI (B and D, E/S/B) before ligation
and DC-PCR analysis. (A and B) PCR using the P1/P4 primer set am-
plifies a 510-bp fragment derived from the vector backbone from pG3.1
and p273. (C and D) PCR with primer set P2/P3g or P2/P3a amplifies
the 180 bp fragment representing the S–S recombinant fragments from
pG3.1 and p273, respectively. Restriction enzymes used in this analysis
were EcoRI (E), SacI (S), and BglI (B).
Table II. Recovery of p273 from Transfected DNA by Bacterial Transformation
Bacterial Ampr * transformants
Cell line
Endogenous 
SR activity n‡ Total§ EcoRIri % EcoRIr¶
EcoRIr-
S–S**
% S–S 
Rec‡‡ P value§§
A20 2 4 23,920 16 0.067 0 ,0.004 NS
EL4 2 4 31,074 18 0.058 0 ,0.003 NS
M12 2 5 51,456 7 0.014 0 ,0.002 NS
CH12.LX 1 4 13,898 16 0.115 10 0.072
1B4.B6.10 1 3 9,584 13 0.136 4 0.041 ,0.001
I.29m 1 4 20,968 39 0.186 28 0.133 ,0.001
B cellsiii 1 2 8,340 21 0.252 12 0.144 ,0.001
Plasmid was transfected into the indicated cell lines. The DNA recovered from nuclei of p273-transfected cells was either left untreated or digested
with EcoRI and then transformed into bacteria. The EcoRIr colonies were prepared as minipreps and analyzed by restriction mapping to identify S–S
recombinant plasmids.
*Ampr denotes ampicillin resistance.
‡Number of individual experiments.
§The total number of Ampr transformants obtained.
iEcoRIr denotes plasmid resistant to EcoRI digestion. Intact plasmids recovered despite EcoRI digestion were excluded.
¶The percentage of EcoRIr is obtained by dividing the total number of EcoRIr transformants by Ampr transformants and then multiplying by 100.
**EcoRIr-S–S denotes bacterial recombinants that carry Sm–Sa recombinant plasmid resistant to EcoRI digestion.
‡‡The percentage of S–S recombinants (S–S Rec) is obtained by dividing the total number of EcoRIr-S–S transformants by Ampr transformants and
then multiplying by 100.
§§The P value indicates the probability that the percentage of S–S recombinants obtained for each cell line is significantly different from that obtained
for CH12LX, the cell line of reference. P values were derived by x2 analysis (see Materials and Methods). NS, not significant.
iiiB cells were stimulated with 50 mg/ml LPS.
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terial transformation. SR on p273 was analyzed in various
cell lines by transient transfection, isolation of DNA from
nuclei, and transformation of bacteria. Recombination be-
tween S regions leads to deletion of TK and loss of a
unique EcoRI restriction site. To identify plasmids that are
S–S recombinant, all recovered plasmids were digested
with EcoRI and resistant plasmids were further analyzed by
restriction enzyme mapping. S–S recombinants were re-
covered from I.29m, CH12.LX, 1B4.B6 cells, and LPS-
activated splenic B cells, whereas none of the p273 recovered
from A20, M12, or EL4 contained S–S recombination
events (Table II). The fraction of recombinant plasmids was
calculated for each cell line and compared with that for
M12 using x2 analysis. The P values derived from the x2
analysis indicate that the switching cell lines are not signifi-
cantly different from each other and are significantly differ-
ent than the nonswitching cell lines with respect to the in-
cidence of S–S recombinant plasmids recovered (Table II).
Although the loss of the EcoRI site located in the TK
gene is diagnostic of an S–S recombinant plasmid, the ab-
sence of this restriction site may also occur when the TK
gene is partially or completely deleted by other types of re-
combination events. The ratio of ampicillin-resistant colo-
nies obtained after digestion with EcoRI, compared with
undigested genomic DNA, indicates the total relative re-
combination frequency. We found that #0.25% of the re-
covered plasmids were EcoRI resistant in all the cell lines
analyzed (Table II). Thus, nearly all the plasmids were in-
tact 2 d after transfection.
Restriction enzyme mapping demonstrated that deletion
of the region spanning the neo gene through the Sa region
was the most frequent event leading to EcoRI resistance in
plasmids from all cell lines tested with the exception of
CH12.LX, I.29m, and normal LPS-activated splenic B
cells, where S–S recombination was more frequent (data
not shown and Table II). The neo-deleted plasmids would
not be detected by direct S–S PCR or by DC-PCR analy-
sis, as the primer annealing sites were lost. These findings
indicate that S–S recombination occurs on p273, which
was transfected into switching cell lines or B cells but not
into other cells. However, our studies also demonstrate that
there is an inherent instability in the S plasmid such that the
region spanning the neo gene through Sa can be deleted in
all the cell types analyzed.
To control for possible S–S recombination in bacteria, in
the same experiments p273 DNA was untreated or di-
gested with EcoRI and transformed into Escherichia coli.
The efficiency of transformation for intact plasmid was 5 3
107 colonies/mg. After transformation with 10 ng of
EcoRI-treated p273, the equivalent of 5 3 105 colonies,
we found no ampicillin-resistant colonies, indicating that
EcoRI resistance arises as a consequence of transfection
into cell lines, and that EcoRI resistance does not arise in
bacteria. Taken together, these results demonstrate that SR
on the p273 plasmid recovered from transfected cell lines is
detectable only in cells that switch, but also that the switch
plasmids are inherently unstable. This instability may arise
from the repetitive character of the S regions.
Switch Junction Sequence Analysis Confirms Direct S–S Re-
combination. The DC-PCR analysis demonstrates the
presence of composite Sm–Sa or Sm–Sg3 on a single SacI
restriction fragment. However, it is still possible that a small
number of nucleotides derived from either TK or Ia are
located between the apparently recombined S regions and
would not be detectable by Southern analysis. S–S recom-
binant p273 plasmids, which had been transfected into
Figure 6. DNA sequence analysis demonstrates direct S–S joining in
recombinant plasmids. Seven Sm–Sa recombinant plasmids were identi-
fied from Hirt extracts of p273-transfected I.29m (R-1 to R-4) and
1B4.B6 (R-6 to R-7) cells after transformation of bacteria (STBL2;
GIBCO BRL). Automated DNA sequence analysis using the m-1A and
the a-R11 primers allowed the determination of the precise Sm–Sa
breakpoints. Brackets around the breakpoints indicate DNA homology
between the Sm donor and Sa acceptor DNAs. Nucleotide position 1 of
the plasmid Sm sequence corresponds to position 5330 of germline Sm se-
quence (sequence data available from EMBL/GenBank/DDBJ under ac-
cession no. MUSIGCD07). Nucleotide position 1 of plasmid Sa sequence
corresponds to position 2121 of the germline Sa sequence (available from
EMBL/GenBank/DDBJ under accession no. MUSIALPHA).
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1B4.B6.10 and I.29m cells, were identified by restriction
mapping (Table II). Nine S–S recombinant plasmids were
taken for DNA sequence analysis and the Sm–Sa switch
junctions were located for seven plasmids (R-1 to R-7;
Fig. 6). Several mutations were found in clones R1, R3,
R4, R6, and R7. However, these mutations were not fully
authenticated as it was only possible to sequence one DNA
strand in the area of the switch junction. In all of these
clones, the switch junctions showed direct joining of Sm
and Sa DNA without deletion, duplication, or nucleotide
insertion at the breakpoint. Identity between the donor and
acceptor S regions is frequently found in switch junctions
(60). The microhomology at the Sm–Sa junctions was 1–14
bases (Fig. 6). This level of homology at the junctions is
slightly higher than usually observed (60), but may not be
surprising given the degree of similarity between the Sm
and Sa regions (49). The recombination breakpoints for
these Sm–Sa switch junctions originate in different posi-
tions within the germline Sm and Sa regions, demon-
strating that the hybrid Sm–Sa molecules arose from in-
dependent recombinational events. It should be stressed
that the S–S recombinant plasmids recovered from switch-
ing cell lines were recombined only between S regions
and contained no other rearrangements or deletions, sug-
gesting that these recombination events arose through bona
fide SR.
SR on pG3.1 Is Switch Region Dependent. SR demon-
strates sequence specificity because it is focused on S region
DNA at endogenous loci. To determine whether plasmid-
based SR was specific for S DNA, a switch plasmid was
constructed in which the Sg3 DNA was largely deleted. In
this plasmid, named pG3.1.01s, all that remained of Sg3
DNA was 125 bp derived from the 39 end of the S region.
The frequency of S–S recombinant plasmids arising from
pG3.1 and pG3.1.01s was compared after transfection into
normal splenic B cells activated with LPS. S–S recombinant
pG3.1 plasmids were recovered, whereas no S–S recombi-
nant pG3.1.01s plasmids were found after transfection (Ta-
ble III). The P values derived from the x2 analysis indicate
that the frequency of S–S recombinant events for pG3.1
was significantly different from that for pG3.1.01s. In addi-
tion, deletion of the Sg3 region leads to enhanced plasmid
stability as evidenced by the z10-fold lower frequency of
EcoRI-resistant pG3.1.01s compared with pG3.1. These
results indicate that the presence of the Sg3 region is cru-
cial for SR to occur on the switch plasmids and demon-
strates the S region dependency of this recombination
event.
Transcriptional Elements Are Not Required for Recombination
on the Switch Substrates. Expression of gts is a prerequisite
for SR in vivo. To determine whether transcription of S
regions is required for SR on plasmid substrates, the RRLs
of structural variants of pG3.1 and p273 that lack the Ia,
EP, or Ia and EP segments were assessed in 1B4.B6 and
I.29m cells, respectively. We found no consistent relation-
ship between the presence or absence of the transcriptional
elements and recombination (Fig. 7). Furthermore, recom-
bination did not depend on the presence of the Ia or EP
segments in stable transfection studies of p273 and its Ia
and Ia plus EP deletion variants (33). The lack of require-
ment for the presence of transcriptional elements may be
due to a low level of transcription on the plasmid occurring
in the absence of the Ia and EP segments. Reverse tran-
scriptase-PCR analysis indicates the occurrence of very
low levels of read-through transcription from the TK pro-
moter through the Sa region in the absence of the Ia pro-
moter (33). However, read-through transcripts through the
Sm region were not detected in the absence of the EP en-
hancer/promoter segment. We conclude that high levels of
transcription are not necessary, and it is unclear whether
any transcription is required for successful SR on the plas-
mid substrate.
Table III. Recovery of pG3.1 and pG3.01s from Transfected DNA by Bacterial Transformation
Bacterial Ampr* transformants
Plasmid n‡ Total§ EcoRIri % EcoRIr¶ EcoRIr-S–S** % S–S Rec‡‡ P value§§
pG3.1 2 23,800 32 0.130 9 0.040
pG3.01s 2 344,000 48 0.014 0 0.000 ,0.0001
Plasmid was transfected into B cells from nu/nu mice stimulated with 50 mg/ml LPS. The DNA recovered from nuclei of transfected cells was either
left untreated, or digested with EcoRI and then transformed into bacteria. The EcoRIr colonies were prepared as minipreps and analyzed by restriction
mapping to identify S–S recombinant plasmids.
*Ampr denotes ampicillin resistance.
‡Number of individual experiments.
§The total number of Ampr transformants obtained.
iEcoRIr denotes plasmid resistant to EcoRI digestion. Intact plasmids recovered despite EcoRI digestion were excluded.
¶The percentage of EcoRIr is obtained by dividing the total number of EcoRIr transformants by Ampr transformants and then multiplying by 100.
**EcoRIr-S–S denotes bacterial transformants that carry Sm–Sa recombinant plasmid resistant to EcoRI digestion.
‡‡The percentage of S–S recombinants (S–S Rec) is obtained by dividing the total number of EcoRIr-S–S transformants by Ampr tranformants and
multiplying by 100.
§§The P value indicated the probability that the percentage of S–S recombinants obtained for pG3.01s is significantly different from that obtained for
pG3.1. P values were derived by x2 analysis (see Materials and Methods).
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Switching Factors Are Constitutively Expressed in Cell Lines
Capable of SR. SR at endogenous loci in the B cell lines
I.29m, CH12.LX, and 1B4.B6 is dependent on cytokine
and/or mitogen stimulation (40, 41, 61, 62). While the role
of cytokines that specifically induce gt expression have
been well defined, the function of mitogen activation is
unknown. The fact that the switch substrates recombine in
unstimulated B cell lines suggests that some of the factors
mediating SR are constitutively expressed. To determine if
stimulation would increase recombination of the switch
substrates, the RRLs for pG3.1 in 1B4.B6.10 cells, and
p273 in 1B4.B6, I.29m, and CH12.LX cells, in both un-
stimulated and stimulated culture conditions were evalu-
ated (Fig. 8 A). No significant difference in recombination
levels was observed. To verify these results, a twofold serial
dilution of ligated DNA taken from the DC-PCR analysis
of p273 transfected into stimulated and unstimulated I.29m
cells (Fig. 8 A) was further analyzed by DC-PCR (Fig. 8
B). The RRLs for unstimulated and stimulated cells are
nearly identical, demonstrating the constitutive expression
of switching factors detected by the switch substrates.
These results prompted us to ask whether splenic B cells
induced to proliferate but not to undergo SR also express
switching factors. To test this, splenic B cells were activated
with addex, which causes B cell proliferation but not SR
(63), and with LPS, which causes both proliferation and
SR of endogenous loci. Activated B cells were transfected
with p273 and analyzed for SR on the plasmid by DC-
PCR. No difference was found between the levels of re-
combination induced by LPS or addex (Fig. 8 C). These
findings demonstrate that plasmid-based SR activity is de-
tectable in proliferating splenic B cells that are not under-
going SR at endogenous loci, and that all the factors re-
quired for exogenous SR reaction are expressed in these
cells.
Discussion
These studies demonstrate that a transiently transfected
plasmid can specifically assay SR. B cell lines and splenic B
cells capable of undergoing SR on their endogenous chro-
mosomes support S–S recombination on the plasmid,
whereas B cells that do not undergo endogenous SR do
not support plasmid SR. The switch plasmids were ana-
Figure 8. Mitogen stimulation of cell
lines has no effect on switch substrate re-
combination. (A) DC-PCR analysis of
DNA from pG3.1- or p273-transfected cell
lines, which were unstimulated (U) or
stimulated (S) for 48 h (top). I.29m was
stimulated with LPS and TGF-b1,
CH12.LX with CD40L and IL-4 as de-
scribed (references 40, 61), and 1B4.B6
with CD40L and LPS (our unpublished
data). The average RRL and SD of four
transfections in two independent experi-
ments for each cell line is shown (bottom).
(B) DC-PCR analysis of the 180-bp frag-
ment from twofold serial dilutions of li-
gated DNA derived from nuclei of I.29m
cells transfected with p273 and grown in
unstimulated (U) and stimulated (S) condi-
tions (top). Quantitation of the 180-bp
fragment resulting from DC-PCR analysis
of serial dilutions of ligated DNA (bottom).
(C) DC-PCR analysis of Hirt extracts from
normal splenic B cells activated with LPS or
addex transfected with p273, as indicated.
Figure 7. Deletion of the transcriptional elements, EP and Ia, does not
affect recombination frequency on the switch plasmids. A schematic of
the pG3.1 and p273 and their respective deletion constructs in which EP
(pG3.DEP, p208) or Ia (pG3.DIa, p200) or EP1Ia (pG3.DIaDEP, p218)
have been removed is shown on the left. DC-PCR analysis of DNA from
nuclei derived from 1B4.B6.10 cells transfected with pG3.1 or deletion
constructs and I.29m cells transfected with p273 or deletion constructs is
summarized on the right as indicated. Each of the plasmids was trans-
fected in triplicate in at least three independent experiments and a repre-
sentative experiment is shown. The RRLs for the parental plasmids
pG3.1 and p273 are arbitrarily set at 1.0. The fold induction indicates the
RRL of the deletion constructs compared with pG3.1 or p273. The his-
tograms are aligned with the appropriate plasmid structure.
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lyzed by direct PCR for S–S recombinant molecules 2 d af-
ter transfection, revealing a heterogeneous population of
substrate-derived S–S composite molecules in switching B
cell lines. A semiquantitative DC-PCR assay confirmed the
presence of S–S composite fragments, demonstrating that
the level of SR activity in switching B cell lines is .80–
200-fold in nonswitching B cell lines. This observation was
confirmed in bacterial transformation studies in which S–S
recombinant plasmids were detected after transfection into
switching cells but not in other cell lines. Analysis of plas-
mid-derived S–S junctions isolated from stable transfectants
(33) or recovered by bacterial transformation after transient
transfection (Fig. 6) demonstrated direct S–S recombina-
tion. Finally, the specificity of the plasmid-based SR was
demonstrated by the finding that SR required the presence
of two S regions but was undetectable when one S region
was deleted.
The mfi a switching activity detected by the switch plas-
mid assay is found only in B cell lines capable of endoge-
nous mfi a SR, suggesting that this activity is not widely
expressed in B cells. Comparison of the recombination po-
tential of switch substrates specific for mfi a and for mfi g3
SR demonstrated the presence of two distinct switching
activities. The mfi g3 switching activity was observed in
the single B cell line capable of endogenous mfi g3 SR and
in mitogen-activated normal B cells, but not in cell lines
capable of only mfi a SR, suggesting that the mfi g3
switching activity is distinct from the mfi a activity. It will
be of significant interest to determine whether individual
switching activities exist for each type of S DNA. It is also
possible that switching activity detected by the switch plas-
mids results from the absence of a suppressor activity rather
than a positive regulator. In this scenario, isotype- or class-
specific suppressors regulate recombination and the selec-
tive expression of the suppressors determines recombination
potential for individual S regions. In either case, these find-
ings demonstrate the existence of transacting factors that in-
fluence the specificity of SR-independent of gt expression.
Our studies clearly establish that ubiquitous recombination
factors cannot be exclusively responsible for SR.
The hypothesis that DNA replication may be a require-
ment for SR was based on the observations that after mito-
gen stimulation several cell cycle divisions occur before iso-
type switching is detectable in B cells (56–59) and that
DNA replication is required for V(D)J recombination on
episomal plasmid substrates (64, 65). Consequently, poly-
oma origins of replication were included in switch plasmids
previously constructed (24, 29). Our switch substrates lack
a eukaryotic origin of replication. We find SR on our
switch plasmids recovered in Hirt extracts, demonstrating
that recombination can occur independent of high level
DNA replication. However, it is currently unclear whether
an origin of replication on the switch plasmids would aug-
ment SR. Moreover, our findings do not preclude the pos-
sibility that error-prone DNA synthesis occurs during the
switching process at the site of recombination between the
Sm donor and the downstream S DNA acceptor, as previ-
ously suggested (9, 66).
The expression of gts is always associated with SR in
vivo (67). Studies in which the I region–associated pro-
moter has been disrupted by targeted recombination indi-
cate that transcription is necessary for SR to ensue (12, 15,
49). In addition, the splice donor located at the 39 end of
the I region must be intact for SR to occur (68, 69). Our
switch plasmids contain transcriptional elements upstream
of the S regions but do not contain RNA splice donors,
normally found upstream of each S region in the endoge-
nous genes. Furthermore, removal of the EP and Ia ele-
ments did not have a measurable effect on plasmid-associ-
ated SR, although deletion of EP and Ia greatly reduces
the level of transcripts detectable from the plasmid Sm and
Sa segments, respectively (33). These data suggest that
transcriptional elements, a splice donor, and high level
transcription are not intrinsic to the mechanism of SR. It is
possible that expression of gts is a requirement for SR asso-
ciated with endogenous genes that are under the additional
constraints of chromatin.
An unanticipated finding was that switching factors that
mediate plasmid-based SR are constitutively expressed in
cell lines capable of SR at endogenous genes. This finding
was also suggested when the p273 switch substrate was
studied in stable transfection experiments (33). This is sur-
prising, as these B cell lines require mitogen activation to
initiate SR at endogenous loci (40, 41, 61, 62). These re-
sults imply that mitogen activation of the B cell lines in-
duces factors that are distinct from the constitutively ex-
pressed activities detected by the switch substrates. These
factors may regulate access of switching factors to the en-
dogenous loci through modulation of chromatin configu-
ration at S DNA. Our studies and the results of Kinoshita
and co-workers (32) suggest that recombination is sup-
pressed at endogenous loci in SR-proficient cell lines and is
regulated by both mitogen-inducible factors and gt expres-
sion. Precedence for the involvement of chromatin in the
regulation of recombination has been established in V(D)J
joining. The recombination activating gene (RAG)-1 and
RAG-2 proteins, which constitute the V(D)J recombinase,
are constitutively expressed in B cells during early develop-
ment, but specific chromatin changes are required to allow
recombinase accessibility to the endogenous loci and to in-
duce cleavage of DNA (70).
Using direct S–S PCR and DC-PCR assays, we have
demonstrated that recombination on the switch plasmids
occurs only in B cell lines capable of switching their en-
dogenous genes (Table I). Previously reported switch plas-
mids recombined in many B cell lines that do not undergo
SR of their endogenous genes and in some T cell lines (22,
25, 29). The discrepancy between these earlier findings and
the results presented here may arise from several factors.
Previous transiently transfected switch substrates contained
polyoma origins of replication that are absent from the
switch substrates reported here. These earlier studies relied
on loss of a selectable marker to score for plasmid-associ-
ated SR. False positives could arise from deletion or partial
deletion of this marker by recombination events other than
SR. Our analysis of rearranged plasmid structures recov-
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ered by bacterial transformation of genomic DNA from
transfected cells indicates that in all cell lines tested, from
0.014 to 0.25% of the plasmids contain deletions of the en-
tire nonvector segment of p273 (Table II). The instability
of the switch plasmids may arise from the presence of tan-
demly repetitive DNA sequence in the S regions that is re-
combinogenic through homologous recombination path-
ways. Our PCR-based SR assays are focused on the
detection of S–S recombinant fragments and thus filter out
other unrelated recombination events. Finally, it may be
most significant that B cell lines that are capable of endoge-
nous SR were not previously tested with isotype-matched
switch plasmids. Thus, the switching activity found with
earlier switch plasmid assays may have resulted from low
level expression of the switching factors in B cells. This low
expression level may be just marginally above background
and could account for the difficulty in separating bona fide
switching events from other recombination events that af-
fect the switch plasmids.
There are similarities between SR and V(D)J joining.
Like SR, V(D)J joining occurs by an intrachromosomal de-
letional process (71, 72). SR is also similar to V(D)J joining
in that DSBs appear to be intermediates in the recombina-
tion reaction (5, 73, 74) and both processes are dependent
on the DSB repair protein complex, DNA-PK (6–8, 75–
77). There are also striking differences between V(D)J join-
ing and SR. RAG-1 and RAG-2, the enzymes that initiate
V(D)J joining, are not involved in SR (78). Furthermore,
V(D)J joining occurs between short, well-defined recombi-
nation signal sequences (79), whereas S regions are com-
posed of arrays of tandem repeats that differ in length and
sequence (49). Although the precise signals that mediate
SR are unknown, the presence of DSBs in S DNA that is
undergoing SR (5) suggest that DNA cleavage is the first
step in the SR reaction. It is possible that the switching fac-
tors detected by our plasmid assay are involved in cleaving
S DNA to form DSBs and to initiate SR. Further investiga-
tion is required to characterize the precise functions carried
out by the switching activities detected by these assays.
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